Literature DB >> 23258127

Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease.

Nosratola D Vaziri1, Jun Yuan, Keith Norris.   

Abstract

BACKGROUND: Chronic kidney disease (CKD) impairs intestinal barrier function which leads to endotoxemia and systemic inflammation. We have found depletion of intestinal epithelial tight junction (TJ) proteins in animals with CKD. We further showed that addition of end-stage renal disease patients' plasma to the culture medium provokes a marked drop in transepithelial electrical resistance (TER) and depletion of TJ proteins in cultured human enterocytes. These effects were less severe with post- than with prehemodialysis plasma, suggesting a role of dialyzable agent(s). This study tested the hypothesis that intestinal barrier dysfunction in uremia may be due to diffusion of urea into the gut and its conversion to ammonia by microbial urease.
METHODS: Human enterocytes (T84 cells) were seeded on Transwell plates and utilized when TER exceeded 1,000 mΩ·cm(2) to ensure full polarization and TJ formation. Confluent cells were then incubated for 24 h in media containing 0, 42 or 74 mg/dl urea or urea plus urease to simulate presence of microbial flora.
RESULTS: At clinically relevant concentrations, urea caused a concentration-dependent fall in TER and the key TJ proteins claudin-1, occludin and zonula occludens 1. The effects of urea were dramatically amplified by urease causing cell detachment, dissipation of TER, and massive loss of TJ proteins.
CONCLUSIONS: Uremia-induced disruption of intestinal TJ and barrier function is, in part, mediated by urea which is generally considered to be a nontoxic retained metabolite. These findings reveal a novel mechanism for a salutary effect of urea-lowering strategies, e.g. low-protein diet and longer and more frequent dialysis regimens in advanced CKD.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23258127      PMCID: PMC3686571          DOI: 10.1159/000345969

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  20 in total

1.  Urea concentration in intestinal fluids in normal and uremic dogs.

Authors:  Y T Lee
Journal:  J Surg Oncol       Date:  1971       Impact factor: 3.454

2.  Pathology of gastrointestinal tract in chronic hemodialysis patients: an autopsy study of 78 cases.

Authors:  N D Vaziri; B Dure-Smith; R Miller; M K Mirahmadi
Journal:  Am J Gastroenterol       Date:  1985-08       Impact factor: 10.864

3.  Intestinal ammonia in uraemia: the effect of a urease inhibitor, acetohydroxamic acid.

Authors:  J D Swales; J D Tange; D J Evans
Journal:  Clin Sci       Date:  1972-01       Impact factor: 6.124

Review 4.  The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia.

Authors:  Jonathan Himmelfarb; Peter Stenvinkel; T Alp Ikizler; Raymond M Hakim
Journal:  Kidney Int       Date:  2002-11       Impact factor: 10.612

5.  Associations between renal function, volume status and endotoxaemia in chronic kidney disease patients.

Authors:  Simone Gonçalves; Roberto Pecoits-Filho; Sônia Perreto; Silvio H Barberato; Andréa E M Stinghen; Emmanuel G A Lima; Roseana Fuerbringer; Sirlene M Sauthier; Miguel C Riella
Journal:  Nephrol Dial Transplant       Date:  2006-07-21       Impact factor: 5.992

6.  A human colonic tumor cell line that maintains vectorial electrolyte transport.

Authors:  K Dharmsathaphorn; J A McRoberts; K G Mandel; L D Tisdale; H Masui
Journal:  Am J Physiol       Date:  1984-02

7.  Impaired intestinal barrier function measured by differently sized polyethylene glycols in patients with chronic renal failure.

Authors:  M Magnusson; K E Magnusson; T Sundqvist; T Denneberg
Journal:  Gut       Date:  1991-07       Impact factor: 23.059

8.  Uremic plasma impairs barrier function and depletes the tight junction protein constituents of intestinal epithelium.

Authors:  Nosratola D Vaziri; Nisa Goshtasbi; Jun Yuan; Stefan Jellbauer; Hamid Moradi; Manuela Raffatellu; Kamyar Kalantar-Zadeh
Journal:  Am J Nephrol       Date:  2012-10-31       Impact factor: 3.754

Review 9.  The gastrointestinal tract in uremia.

Authors:  J Y Kang
Journal:  Dig Dis Sci       Date:  1993-02       Impact factor: 3.199

10.  Occluding junction structure-function relationships in a cultured epithelial monolayer.

Authors:  J L Madara; K Dharmsathaphorn
Journal:  J Cell Biol       Date:  1985-12       Impact factor: 10.539

View more
  116 in total

1.  Role of Nrf2 dysfunction in uremia-associated intestinal inflammation and epithelial barrier disruption.

Authors:  Wei Ling Lau; Shu-Man Liu; Sogol Pahlevan; Jun Yuan; Mahyar Khazaeli; Zhenmin Ni; Jefferson Y Chan; Nosratola D Vaziri
Journal:  Dig Dis Sci       Date:  2014-11-16       Impact factor: 3.199

Review 2.  Probiotics and chronic kidney disease.

Authors:  Laetitia Koppe; Denise Mafra; Denis Fouque
Journal:  Kidney Int       Date:  2015-09-16       Impact factor: 10.612

3.  Effect of Synbiotic Therapy on Gut-Derived Uremic Toxins and the Intestinal Microbiome in Patients with CKD.

Authors:  Nosratola D Vaziri
Journal:  Clin J Am Soc Nephrol       Date:  2016-01-15       Impact factor: 8.237

4.  Effects of dietary fibre and protein on urea transport across the cecal mucosa of piglets.

Authors:  F Stumpff; U Lodemann; A G Van Kessel; R Pieper; S Klingspor; K Wolf; H Martens; J Zentek; J R Aschenbach
Journal:  J Comp Physiol B       Date:  2013-06-29       Impact factor: 2.200

5.  Indoxyl sulfate associates with cardiovascular phenotype in children with chronic kidney disease.

Authors:  Johannes Holle; Uwe Querfeld; Marietta Kirchner; Alexandros Anninos; Jürgen Okun; Daniela Thurn-Valsassina; Aysun Bayazit; Ana Niemirska; Nur Canpolat; Ipek Kaplan Bulut; Ali Duzova; Ali Anarat; Rukshana Shroff; Yelda Bilginer; Salim Caliskan; Cengiz Candan; Jerome Harambat; Zeynep Birsin Özcakar; Oguz Soylemezoglu; Sibylle Tschumi; Sandra Habbig; Ebru Yilmaz; Ayse Balat; Aleksandra Zurowska; Nilgun Cakar; Birgitta Kranz; Pelin Ertan; Anette Melk; Karolis Azukaitis; Franz Schaefer
Journal:  Pediatr Nephrol       Date:  2019-08-19       Impact factor: 3.714

6.  Fecal microbiota analysis of polycystic kidney disease patients according to renal function: A pilot study.

Authors:  Rabi Yacoub; Girish N Nadkarni; Daniel I McSkimming; Lee D Chaves; Sham Abyad; Mark A Bryniarski; Amanda M Honan; Shruthi A Thomas; Madan Gowda; John C He; Jaime Uribarri
Journal:  Exp Biol Med (Maywood)       Date:  2018-12-12

Review 7.  Microbiota issue in CKD: how promising are gut-targeted approaches?

Authors:  Carmela Cosola; Maria Teresa Rocchetti; Alice Sabatino; Enrico Fiaccadori; Biagio Raffaele Di Iorio; Loreto Gesualdo
Journal:  J Nephrol       Date:  2018-08-01       Impact factor: 3.902

Review 8.  Once upon a time in dialysis: the last days of Kt/V?

Authors:  Raymond Vanholder; Griet Glorieux; Sunny Eloot
Journal:  Kidney Int       Date:  2015-06-10       Impact factor: 10.612

Review 9.  Metabolic Abnormalities in Diabetes and Kidney Disease: Role of Uremic Toxins.

Authors:  Laetitia Koppe; Denis Fouque; Christophe O Soulage
Journal:  Curr Diab Rep       Date:  2018-09-08       Impact factor: 4.810

10.  Urea impairs β cell glycolysis and insulin secretion in chronic kidney disease.

Authors:  Laetitia Koppe; Elsa Nyam; Kevin Vivot; Jocelyn E Manning Fox; Xiao-Qing Dai; Bich N Nguyen; Dominique Trudel; Camille Attané; Valentine S Moullé; Patrick E MacDonald; Julien Ghislain; Vincent Poitout
Journal:  J Clin Invest       Date:  2016-08-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.